S
Stockadora

Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 3910 Reports
🤖 AI Analyzed
Recent
📄 Page 202 of 326
Seapeak LLC
20-F March 18, 2026

Key Highlights

  • Specializes in LNG and NGL transport with stable revenue from long-term timechar...
  • Actively participates in key joint ventures, expanding its operational footprint...
  • Secured a new charter for the "Marvel Swan" vessel starting in 2025, signaling c...
Read Analysis
🤖 AI Generated
TSS, Inc.
10-K March 18, 2026

Key Highlights

  • Aggressively expanded into the burgeoning Artificial Intelligence (AI) market wi...
  • Secured a multi-year, high-volume agreement with a major US-based OEM for AI-ena...
  • Relocated to a larger, state-of-the-art Georgetown facility, significantly incre...
Read Analysis
🤖 AI Generated
EBR Systems, Inc.
10-K March 18, 2026

Key Highlights

  • Achieved 120% revenue growth to $18.5 million for the fiscal year ended December...
  • Expanded market access with full reimbursement in Germany and commercial launche...
  • Published positive long-term data from the pivotal SOLVE-CRT study, reinforcing ...
Read Analysis
🤖 AI Generated
ONE STOP SYSTEMS, INC.
10-K March 18, 2026

Key Highlights

  • Achieved modest 5% revenue growth in 2025, driven by increased demand for AI-foc...
  • Successfully launched the new 'AI-Edge' computing platform and secured key desig...
  • Expanded European market presence, with its German subsidiary contributing 25% o...
Read Analysis
🤖 AI Generated
Vyome Holdings, Inc
10-K March 18, 2026

Key Highlights

  • Successfully completed a reverse merger on August 15, 2025, making Vyome Holding...
  • Advancing clinical pipeline with VT-1953 progressing to Phase 3 and VT-1908 init...
  • Utilizing a 'Smart Drug Development' approach, focusing on drug repurposing for ...
Read Analysis
🤖 AI Generated
InspireMD, Inc.
10-K March 18, 2026

Key Highlights

  • InspireMD develops and commercializes medical devices for vascular conditions, w...
  • CGuard EPS offers unique design and clinical benefits for superior embolic prote...
  • The company operates in a promising medical device sector addressing critical he...
Read Analysis
🤖 AI Generated
Mastech Digital, Inc.
10-K March 18, 2026

Key Highlights

  • Strategic pivot towards high-growth AI/ML services, generating $1.2 million in i...
  • Successful expansion with existing financial services clients, securing $5 milli...
  • Resilient Data & Analytics segment, growing by 5% despite a 3.5% overall revenue...
Read Analysis
🤖 AI Generated
Avidbank Holdings, Inc.
10-K March 18, 2026

Key Highlights

  • Avidbank reported zero loans across all categories that were 30, 60, or 90+ days...
  • The Commercial Real Estate loan portfolio grew significantly from $15.0 million ...
  • The bank maintains a strong capital position and robust asset quality, providing...
Read Analysis
🤖 AI Generated
Heartflow, Inc.
10-K March 18, 2026

Key Highlights

  • Successful Initial Public Offering (IPO) on August 11, 2023, raising substantial...
  • Robust revenue growth of $150 million, a 30% increase over the previous fiscal y...
  • Proprietary AI-powered platform for non-invasive cardiovascular diagnosis, impro...
Read Analysis
🤖 AI Generated
Golden Growers Cooperative
10-K March 18, 2026

Key Highlights

  • Golden Growers Cooperative (GGC) is officially dissolving and liquidating.
  • Cargill Incorporated will acquire GGC's 50% interest in ProGold for $81 million ...
  • The $81 million sale price represents a significant premium over ProGold's book ...
Read Analysis
🤖 AI Generated
Processa Pharmaceuticals, Inc.
10-K March 18, 2026

Key Highlights

  • Advancing a pipeline with PCS6422 for mCRC and PCS499 for Necrobiosis Lipoidica,...
  • Utilizing a 'Next Generation Cancer therapy' (NGC) strategy to improve existing ...
  • Exploring digital assets for non-dilutive funding of drug development, aiming to...
Read Analysis
🤖 AI Generated
SERA PROGNOSTICS, INC.
10-K March 18, 2026

Key Highlights

  • 35% revenue growth to $5.2 million, indicating early market penetration for its ...
  • Flagship PreTRM test is gaining increased clinical adoption and payer coverage, ...
  • Significant ongoing investments in research and development, clinical studies, a...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage